BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5031032)

  • 1. [Preliminary clinico-geriatric trials of S-adenosylmethionine (coenzyme of biologic transmethylation)].
    Cavalieri U; Leonelli G
    Minerva Med; 1972 May; 63(37):2120-5. PubMed ID: 5031032
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various effects of SAM dependent transmethylations in hepatology].
    Labò G; Gasbarrini G; Miglio F
    Minerva Med; 1972 May; 63(35):2007-17. PubMed ID: 5029206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes induced by S-adenosylmethionine (SAM) in the cholesterol and triglyceride plasma levels and in the beta-alpha lipoprotein ratio in cases of hyperlipemia. (Preliminary note)].
    Menci S; Orsucci PL
    G Gerontol; 1972 Jun; 20(6):523-33. PubMed ID: 5046892
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical use of S-adenosylmethionine].
    Mato JM; Alvarez Chiva V
    Rev Clin Esp; 1983 Jan; 168(2):149-50. PubMed ID: 6856905
    [No Abstract]   [Full Text] [Related]  

  • 5. [S-adenosylmethionine (SAM) in geriatric therapy].
    Jori E; Dallari A
    Minerva Med; 1973 Sep; 64(67):3485-91. PubMed ID: 4746873
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].
    De Caprio M; Carbone G; Cerotto GM; Corbosiero L; Vitale A
    Clin Ter; 1980 Mar; 92(6):587-602. PubMed ID: 7460488
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic indications of S-adenosyl methionine in neuropsychiatry].
    Tramoni AV; Azorin JM
    Encephale; 1988; 14(3):113-8. PubMed ID: 2900133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychiatric disorders and transmethylation: therapeutic effects of S-adenosyl-L-methionine].
    Agnoli A; Fazio C; Andreoli V; De Carolis V; Bonamini F; Pastorino P; Casacchia M; Cerbo R; Ruggieri S; Carolei A
    Clin Ter; 1975 Dec; 75(6):567-79. PubMed ID: 767041
    [No Abstract]   [Full Text] [Related]  

  • 10. [Emergency drug therapy of internal diseases (discussion)].
    Nihon Naika Gakkai Zasshi; 1995 Nov; 84(11):1876-93. PubMed ID: 8568390
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ademetionine: the state of the art and future prospects].
    Almasio P; Pagliaro L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():52S-55S. PubMed ID: 8117523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New trends in the therapy of chronic liver diseases. Significance of Sam-dependent transmethylations].
    Garassini G; Sarnari V
    Minerva Gastroenterol; 1974; 20(1):19-26. PubMed ID: 4827982
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the one-carbon cycle in neuropsychiatric disease.
    Smythies JR
    Biol Psychiatry; 1984 May; 19(5):755-8. PubMed ID: 6329330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary note on the use of high doses of S-adenosylmethionine].
    Sabbatini F; Lorenzini R; De Michelis G
    Minerva Psichiatr; 1983; 24(1):33-5. PubMed ID: 6621302
    [No Abstract]   [Full Text] [Related]  

  • 15. [A trial of using Geptral in patients with chronic liver diseases].
    Gorbakov VV; Kalinin AV; Ermolin SN
    Voen Med Zh; 1996 Dec; 317(12):29-31. PubMed ID: 9163214
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical pharmacology of adenine nucleotides (review of the literature)].
    Chakman IS; Kava TV; Potemkina NN; Tumanov VA
    Vrach Delo; 1985 Apr; (4):12-6. PubMed ID: 2861692
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of methionine in liver disease.
    Mato JM; Ortiz P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():35-46. PubMed ID: 8899692
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.
    Albizzati MG; Bassi S; Sbacchi M; Frattola L
    Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327
    [No Abstract]   [Full Text] [Related]  

  • 19. Mental functioning following cardiovascular and cerebrovascular disease.
    W V Med J; 1966 Mar; 62(3):81-2. PubMed ID: 5217786
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ambulatory treatment of hepatic damage: comparison of 2 therapeutic modalities].
    Ravetta A
    Clin Ter; 1981 Oct; 99(2):149-53. PubMed ID: 7318368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.